The Board of Directors of Guangzhou Wondfo Biotech Co.,Ltd has authorized a buyback plan on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.89 CNY | +0.47% | -0.07% | -7.56% |
May. 06 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
Apr. 21 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.56% | 1.79B | |
-3.43% | 12.1B | |
-3.17% | 8.24B | |
+31.98% | 5.58B | |
-10.03% | 4.15B | |
-59.94% | 2.68B | |
+11.23% | 2.63B | |
-5.14% | 2.24B | |
+18.91% | 2.03B | |
+3.07% | 1.56B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.